Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-18-011172)

Filing Details

Accession Number:: 0001179110-18-011172
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-09-06 18:44:04
Reporting Period:: 2018-09-04

Accepted Time:: 2018-09-06 18:44:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
896264	Usana Health Sciences Inc	USNA	Medicinal Chemicals & Botanical Products (2833)	870500306

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1555707	Jim Brown	3838 West Parkway Blvd. Salt Lake City UT 84120	President & Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-09-04	2,400	$70.75	2,400	No	4	M	Direct
Common Stock	Disposition	2018-09-04	2,400	$130.09	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Settled Stock Appreciation Rights	Disposition	2018-09-04	5,266	$0.00	5,266	$70.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
54,734	2018-09-01	2020-03-01	No	4	M	Direct

Footnotes

The shares acquired resulted from reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II
Weighted average price $130.085. Price range in multiple transactions was $130.00 to $130.55 inclusively.